Literature DB >> 28449098

Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Christian P Ahearn1,2, Mary C Gallo1,2, Timothy F Murphy1,2,3.   

Abstract

Non-typeable Haemophilus influenzae (NTHi) is the most common bacterial cause of infection of the lower airways in adults with chronic obstructive pulmonary disease (COPD). Infection of the COPD airways causes acute exacerbations, resulting in substantial morbidity and mortality. NTHi has evolved multiple mechanisms to establish infection in the hostile environment of the COPD airways, allowing the pathogen to persist in the airways for months to years. Persistent infection of the COPD airways contributes to chronic airway inflammation that increases symptoms and accelerates the progressive loss of pulmonary function, which is a hallmark of the disease. Persistence mechanisms of NTHi include the expression of multiple redundant adhesins that mediate binding to host cellular and extracellular matrix components. NTHi evades host immune recognition and clearance by invading host epithelial cells, forming biofilms, altering gene expression and displaying surface antigenic variation. NTHi also binds host serum factors that confer serum resistance. Here we discuss the burden of COPD and the role of NTHi infections in the course of the disease. We provide an overview of NTHi mechanisms of persistence that allow the pathogen to establish a niche in the hostile COPD airways. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chronic obstructive pulmonary disease; immune evasion; mechanisms of persistence; non-typeable Haemophilus influenzae; persistent infection

Mesh:

Year:  2017        PMID: 28449098      PMCID: PMC5437125          DOI: 10.1093/femspd/ftx042

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  200 in total

1.  Smoke induced changes in epithelial cell gene expression: development of an in vitro model for COPD.

Authors:  Ruzica Puljic; Andreas Pahl
Journal:  ALTEX       Date:  2004       Impact factor: 6.043

2.  Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media.

Authors:  Wenzhou Hong; Richard A Juneau; Bing Pang; W Edward Swords
Journal:  J Innate Immun       Date:  2009-02-27       Impact factor: 7.349

3.  Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size.

Authors:  Jennifer L Reimche; Daniel J Kirse; Amy S Whigham; W Edward Swords
Journal:  Pathog Dis       Date:  2016-12-11       Impact factor: 3.166

Review 4.  Haemophilus influenzae and the complement system.

Authors:  Teresia Hallström; Kristian Riesbeck
Journal:  Trends Microbiol       Date:  2010-06       Impact factor: 17.079

5.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Intercellular adhesion molecule 1 serves as a primary cognate receptor for the Type IV pilus of nontypeable Haemophilus influenzae.

Authors:  Laura A Novotny; Lauren O Bakaletz
Journal:  Cell Microbiol       Date:  2016-02-26       Impact factor: 3.715

7.  The Haemophilus influenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain.

Authors:  Doran L Fink; Amy Z Buscher; Bruce Green; Phillip Fernsten; Joseph W St Geme
Journal:  Cell Microbiol       Date:  2003-03       Impact factor: 3.715

8.  Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.

Authors:  Timothy D Starner; Joshua D Shrout; Matthew R Parsek; Peter C Appelbaum; GunHee Kim
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

9.  Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity.

Authors:  Elena Ronander; Marta Brant; Emily Eriksson; Matthias Mörgelin; Oskar Hallgren; Gunilla Westergren-Thorsson; Arne Forsgren; Kristian Riesbeck
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

Review 10.  Viral-bacterial co-infections in the respiratory tract.

Authors:  Lauren O Bakaletz
Journal:  Curr Opin Microbiol       Date:  2016-12-07       Impact factor: 7.934

View more
  35 in total

1.  Discovery and Contribution of Nontypeable Haemophilus influenzae NTHI1441 to Human Respiratory Epithelial Cell Invasion.

Authors:  C P Ahearn; C Kirkham; L D Chaves; Y Kong; M M Pettigrew; T F Murphy
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

3.  Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement.

Authors:  Mary Darby Jackson; Sandy M Wong; Brian J Akerley
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

4.  Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.

Authors:  Elaine M Mokrzan; Taylor J Johnson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  Changes in IgA Protease Expression Are Conferred by Changes in Genomes during Persistent Infection by Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.

Authors:  Mary C Gallo; Charmaine Kirkham; Samantha Eng; Remon S Bebawee; Yong Kong; Melinda M Pettigrew; Hervé Tettelin; Timothy F Murphy
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

6.  Nontypeable Haemophilus influenzae Type IV Pilus Mediates Augmented Adherence to Rhinovirus-Infected Human Airway Epithelial Cells.

Authors:  Stephen L Toone; Michelle Ratkiewicz; Laura A Novotny; Binh L Phong; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

7.  Immunoglobulin A Protease Variants Facilitate Intracellular Survival in Epithelial Cells By Nontypeable Haemophilus influenzae That Persist in the Human Respiratory Tract in Chronic Obstructive Pulmonary Disease.

Authors:  Timothy F Murphy; Charmaine Kirkham; Mary C Gallo; Yang Yang; Gregory E Wilding; Melinda M Pettigrew
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

8.  Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection.

Authors:  Ariadna Fernández-Calvet; Begoña Euba; Celia Gil-Campillo; Arancha Catalan-Moreno; Javier Moleres; Sara Martí; Alexandra Merlos; Jeroen D Langereis; Francisco García-Del Portillo; Lauren O Bakaletz; Garth D Ehrlich; Eric A Porsch; Margarita Menéndez; Joshua C Mell; Alejandro Toledo-Arana; Junkal Garmendia
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

Review 9.  Interaction with the host: the role of fibronectin and extracellular matrix proteins in the adhesion of Gram-negative bacteria.

Authors:  Diana J Vaca; Arno Thibau; Monika Schütz; Peter Kraiczy; Lotta Happonen; Johan Malmström; Volkhard A J Kempf
Journal:  Med Microbiol Immunol       Date:  2019-11-29       Impact factor: 3.402

10.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.